NYSE · COHRHealthcareOptical Instruments

Coherent financials

$292.21+3.46%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Jun 30
FY25
Jun 30
FY24
Jun 30
FY23
Jun 30
Revenue$7.12B$5.81B$4.71B$5.16B
Gross profit$2.67B$2.04B$1.46B$1.62B
Gross margin37.5%35.2%30.9%31.4%
Operating income$913.9M$337.4M$140.8M-$37.1M
Net income$769.9M-$80.6M-$279.5M-$403.7M
Net margin10.8%−1.4%−5.9%−7.8%
Diluted EPS$4.12$-0.52$-1.84$-2.93
EBITDA$1.56B$1.14B$727.6M$763.7M
Operating cash flow$79.5M$633.6M$545.7M$634.0M
Free cash flow-$1.02B$192.8M$198.9M$198.0M
Diluted shares195.4M154.8M151.6M137.6M

Balance sheet

Period endJun 30Jun 30Jun 30Jun 30
Cash & equivalents$1.16B$909.2M$926.0M$821.3M
Short-term investments$825.0M$0.00$0.00$0.00
Total debt$3.22B$3.69B$4.10B$4.31B
Total assets$18.30B$14.91B$14.49B$13.71B
Total liabilities$7.06B$6.43B$6.54B$6.48B
Shareholders' equity$11.24B$6.00B$5.58B$4.99B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology